The Long Game In Life Sciences: $181 Billion Fund Baillie Gifford Invests Big In Private Companies

Deep-pocketed Edinburgh-based investor Baillie Gifford forges a new path in long-term, hands-off investing in life sciences companies such as Flatiron Health, Denali Therapeutics, CureVac, Intarcia, UNITY Biotechnology and Ginkgo Bioworks.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NASDAQ:AMZN NASDAQ:TSLA NASDAQ:ILMN NASDAQ:CSLT NASDAQ:ISRG Source Type: news